Doxorubicin Hydrochloride Injection, Suspension, Liposomal
Product Images NDC 75907-364

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 75907-364). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxorubicin-10ml-carton-drl (Doxorubicin 10ml Carton Drl)

Packaging label for doxorubicin hydrochloride liposome injection, 20 mg/10 mL (2 mg/mL) in a 10 mL single-dose vial by Dr. Reddy's Laboratories Inc. The label states it is for intravenous infusion only after dilution, cytotoxic, and includes storage instructions to refrigerate between 2° to 8°C and not freeze. The label also highlights it as a liposomal formulation and cautions not to substitute it for non-liposomal doxorubicin hydrochloride.*

FDA Label Image

Doxorubicin-10ml-vial-drl (Doxorubicin 10ml Vial Drl)

Label for Doxorubicin Hydrochloride Liposome Injection, 20 mg per 10 mL (2 mg/mL) intravenous injection, suspension, liposomal. Single-dose 10 mL vial. Contains warnings about the liposomal formulation advising no substitution. Manufactured for Dr. Reddy's Laboratories Inc., Princeton, NJ, USA, product of Germany. Includes storage instructions, lot number area, barcode, and reminder to discard unused portions.*

FDA Label Image

Doxorubicin-25ml-carton-drl (Doxorubicin 25ml Carton Drl)

Packaging label for DOXOrubicin Hydrochloride Liposome Injection 50 mg/25 mL (2 mg/mL) in a 25 mL single-dose vial. The product is a cytotoxic, liposomal formulation for intravenous infusion only after dilution, manufactured by Dr. Reddy's Laboratories Inc. Storage instructions specify refrigeration at 2° to 8°C (36° to 46°F) and do not freeze. Warning states not to substitute for doxorubicin hydrochloride.*

FDA Label Image

Doxorubicin-25ml-vial-drl (Doxorubicin 25ml Vial Drl)

Label for doxorubicin hydrochloride liposome injection, 50 mg per 25 mL single-dose vial (2 mg/mL) by Dr. Reddy's Laboratories Inc. It is a liposomal formulation for intravenous infusion only after dilution. The label includes storage instructions, manufacturer location in Princeton, NJ, and states the product is made in Germany.*

FDA Label Image

Doxorubicin-figure-1 (Doxorubicin Figure 1)

Kaplan-Meier survival curve comparing progression-free survival over time (in months) between two groups: Doxorubicin HCl combined with Bortezomib and Bortezomib alone. The y-axis shows the percent of subjects progression-free. The chart includes the number of subjects at risk at each time point for both groups and statistical values including p-value < 0.0001 and hazard ratio (HR) with 95% confidence interval.*

FDA Label Image

Doxorubicin-hspe (Doxorubicin Hspe)

Chemical structure diagram of doxorubicin hydrochloride, showing molecular bonds and functional groups relevant to the active ingredient.*

FDA Label Image

Doxorubicin-mpeg-dspe (Doxorubicin Mpeg Dspe)

Chemical structure diagram of a liposomal component associated with doxorubicin hydrochloride injection, suspension, liposomal formulation. The structure shows a phospholipid molecule with hydrophobic hydrocarbon chains and hydrophilic head groups, including phosphate and sodium ions, representing the lipid composition in the liposomal drug delivery form.*

FDA Label Image

Doxorubicin-pegylated-liposome (Doxorubicin Pegylated Liposome)

An illustration diagram showing the structure of a liposomal formulation of doxorubicin hydrochloride. It highlights the MPEG-DSPE coating on the outer surface, an aqueous core containing entrapped doxorubicin HCl, and the liposomal bilayer surrounding the core.*

FDA Label Image

Doxorubicin-structure. (Doxorubicin Structure)

Chemical structure of doxorubicin hydrochloride, shown as a molecular diagram with labeled rings, functional groups, and the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.